Japan Biotechnology Promotion Group Reveals Measures To Accelerate New Drug Development
This article was originally published in PharmAsia News
Executive Summary
A public-private sector alliance to promote biotechnology in Japan revealed a plan Dec. 11 to speed up new drug development. Named Dream BT Japan, the plan outlines strategies to promote commercialization of research in induced Pluripotent stem cells and speed up new drug development. Details include budget increases for basic research and educating intellectual property specialists. The group is composed of 18 members, including officers from the Ministries of Health, Agriculture, Trade and Industry, Environment and related experts. (Click here for more - Japanese language